TrialMuscle & nerve2025

A Phase 1, Double-Blind, Placebo-Controlled Trial of Sevasemten (EDG-5506), a Selective Modulator of Fast Skeletal Muscle Contraction, in Healthy Volunteers and Adults With Becker Muscular Dystrophy.

Joanne Donovan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.